In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses treatment options for chronic kidney disease patients with ...

Peter L. Salgo, MD: We’re going to be talking about anemia here. What percentage of the chronic kidney disease [CKD] population gets anemic, and what is the etiology of the anemia? Robert Provenzano, ...

Underuse of erythropoiesis-stimulating agents (ESA) and ESA hyporesponsiveness are 2 important reasons for red blood cell transfusion, according to a recent review. It is difficult to avoid the use of ...

The presence and severity of anemia in kidney disease increasesmarkedly with lower estimated glomerular filtration rates (eGFRs) and is associated with multiple adverse outcomes, a large cohort study ...

Oral vadadustat, one of a new class of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), is effective in the treatment of anemia in people with chronic kidney disease (CKD), but ...

Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...

WATERTOWN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for ...

Akebia Therapeutics, Inc. AKBA announced that the FDA has approved its Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD). The eligible patient population for ...